Teva Fined Half A Billion Dollars Over European Copaxone Antitrust Breach

Firm Says Decision Is ‘Not Supported By Facts’ And Vows Appeal

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".